0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Erectile Dysfunction Treatment Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-15F1098
Home | Market Reports | Health| Reproductive Health
Global Erectile Dysfunction Treatment Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Erectile Dysfunction Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-15F1098
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Erectile Dysfunction Treatment Drugs Market Size

The global market for Erectile Dysfunction Treatment Drugs was valued at US$ 5226 million in the year 2024 and is projected to reach a revised size of US$ 6697 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Erectile Dysfunction Treatment Drugs Market

Erectile Dysfunction Treatment Drugs Market

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Treatment Drugs.
The Erectile Dysfunction Treatment Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Erectile Dysfunction Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Treatment Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Erectile Dysfunction Treatment Drugs Market Report

Report Metric Details
Report Name Erectile Dysfunction Treatment Drugs Market
Accounted market size in year US$ 5226 million
Forecasted market size in 2031 US$ 6697 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Phosphodiesterase Type 5 Inhibitors
  • Prostaglandin E1
Segment by Application
  • Hospitals
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer Inc., Dong-A Pharmaceutical Co. Ltd, Vivus, Inc., Meda Pharmaceuticals, Bayer AG, Johnson & Johnson Services, Apricus Biosciences, Eli Lilly
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Erectile Dysfunction Treatment Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Erectile Dysfunction Treatment Drugs Market growing?

Ans: The Erectile Dysfunction Treatment Drugs Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Erectile Dysfunction Treatment Drugs Market size in 2031?

Ans: The Erectile Dysfunction Treatment Drugs Market size in 2031 will be US$ 6697 million.

Who are the main players in the Erectile Dysfunction Treatment Drugs Market report?

Ans: The main players in the Erectile Dysfunction Treatment Drugs Market are Pfizer Inc., Dong-A Pharmaceutical Co. Ltd, Vivus, Inc., Meda Pharmaceuticals, Bayer AG, Johnson & Johnson Services, Apricus Biosciences, Eli Lilly

What are the Application segmentation covered in the Erectile Dysfunction Treatment Drugs Market report?

Ans: The Applications covered in the Erectile Dysfunction Treatment Drugs Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Erectile Dysfunction Treatment Drugs Market report?

Ans: The Types covered in the Erectile Dysfunction Treatment Drugs Market report are Phosphodiesterase Type 5 Inhibitors, Prostaglandin E1

Recommended Reports

Urology & Men's Health

Sexual & Reproductive Health

Cardiovascular & Chronic

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Phosphodiesterase Type 5 Inhibitors
1.2.3 Prostaglandin E1
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Treatment Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Erectile Dysfunction Treatment Drugs Market Perspective (2020-2031)
2.2 Global Erectile Dysfunction Treatment Drugs Growth Trends by Region
2.2.1 Global Erectile Dysfunction Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Erectile Dysfunction Treatment Drugs Historic Market Size by Region (2020-2025)
2.2.3 Erectile Dysfunction Treatment Drugs Forecasted Market Size by Region (2026-2031)
2.3 Erectile Dysfunction Treatment Drugs Market Dynamics
2.3.1 Erectile Dysfunction Treatment Drugs Industry Trends
2.3.2 Erectile Dysfunction Treatment Drugs Market Drivers
2.3.3 Erectile Dysfunction Treatment Drugs Market Challenges
2.3.4 Erectile Dysfunction Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Erectile Dysfunction Treatment Drugs Players by Revenue
3.1.1 Global Top Erectile Dysfunction Treatment Drugs Players by Revenue (2020-2025)
3.1.2 Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Erectile Dysfunction Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Erectile Dysfunction Treatment Drugs Revenue
3.4 Global Erectile Dysfunction Treatment Drugs Market Concentration Ratio
3.4.1 Global Erectile Dysfunction Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erectile Dysfunction Treatment Drugs Revenue in 2024
3.5 Global Key Players of Erectile Dysfunction Treatment Drugs Head office and Area Served
3.6 Global Key Players of Erectile Dysfunction Treatment Drugs, Product and Application
3.7 Global Key Players of Erectile Dysfunction Treatment Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Erectile Dysfunction Treatment Drugs Breakdown Data by Type
4.1 Global Erectile Dysfunction Treatment Drugs Historic Market Size by Type (2020-2025)
4.2 Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Type (2026-2031)
5 Erectile Dysfunction Treatment Drugs Breakdown Data by Application
5.1 Global Erectile Dysfunction Treatment Drugs Historic Market Size by Application (2020-2025)
5.2 Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Erectile Dysfunction Treatment Drugs Market Size (2020-2031)
6.2 North America Erectile Dysfunction Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Erectile Dysfunction Treatment Drugs Market Size by Country (2020-2025)
6.4 North America Erectile Dysfunction Treatment Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Erectile Dysfunction Treatment Drugs Market Size (2020-2031)
7.2 Europe Erectile Dysfunction Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2020-2025)
7.4 Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size (2020-2031)
8.2 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Erectile Dysfunction Treatment Drugs Market Size (2020-2031)
9.2 Latin America Erectile Dysfunction Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2020-2025)
9.4 Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size (2020-2031)
10.2 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Erectile Dysfunction Treatment Drugs Introduction
11.1.4 Pfizer Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Dong-A Pharmaceutical Co. Ltd
11.2.1 Dong-A Pharmaceutical Co. Ltd Company Details
11.2.2 Dong-A Pharmaceutical Co. Ltd Business Overview
11.2.3 Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Introduction
11.2.4 Dong-A Pharmaceutical Co. Ltd Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025)
11.2.5 Dong-A Pharmaceutical Co. Ltd Recent Development
11.3 Vivus, Inc.
11.3.1 Vivus, Inc. Company Details
11.3.2 Vivus, Inc. Business Overview
11.3.3 Vivus, Inc. Erectile Dysfunction Treatment Drugs Introduction
11.3.4 Vivus, Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025)
11.3.5 Vivus, Inc. Recent Development
11.4 Meda Pharmaceuticals
11.4.1 Meda Pharmaceuticals Company Details
11.4.2 Meda Pharmaceuticals Business Overview
11.4.3 Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Introduction
11.4.4 Meda Pharmaceuticals Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025)
11.4.5 Meda Pharmaceuticals Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Erectile Dysfunction Treatment Drugs Introduction
11.5.4 Bayer AG Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025)
11.5.5 Bayer AG Recent Development
11.6 Johnson & Johnson Services
11.6.1 Johnson & Johnson Services Company Details
11.6.2 Johnson & Johnson Services Business Overview
11.6.3 Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Introduction
11.6.4 Johnson & Johnson Services Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025)
11.6.5 Johnson & Johnson Services Recent Development
11.7 Apricus Biosciences
11.7.1 Apricus Biosciences Company Details
11.7.2 Apricus Biosciences Business Overview
11.7.3 Apricus Biosciences Erectile Dysfunction Treatment Drugs Introduction
11.7.4 Apricus Biosciences Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025)
11.7.5 Apricus Biosciences Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Details
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Erectile Dysfunction Treatment Drugs Introduction
11.8.4 Eli Lilly Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025)
11.8.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Phosphodiesterase Type 5 Inhibitors
 Table 3. Key Players of Prostaglandin E1
 Table 4. Global Erectile Dysfunction Treatment Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Erectile Dysfunction Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Erectile Dysfunction Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Erectile Dysfunction Treatment Drugs Market Share by Region (2020-2025)
 Table 8. Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Erectile Dysfunction Treatment Drugs Market Share by Region (2026-2031)
 Table 10. Erectile Dysfunction Treatment Drugs Market Trends
 Table 11. Erectile Dysfunction Treatment Drugs Market Drivers
 Table 12. Erectile Dysfunction Treatment Drugs Market Challenges
 Table 13. Erectile Dysfunction Treatment Drugs Market Restraints
 Table 14. Global Erectile Dysfunction Treatment Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Erectile Dysfunction Treatment Drugs Market Share by Players (2020-2025)
 Table 16. Global Top Erectile Dysfunction Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Treatment Drugs as of 2024)
 Table 17. Ranking of Global Top Erectile Dysfunction Treatment Drugs Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Erectile Dysfunction Treatment Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Erectile Dysfunction Treatment Drugs, Headquarters and Area Served
 Table 20. Global Key Players of Erectile Dysfunction Treatment Drugs, Product and Application
 Table 21. Global Key Players of Erectile Dysfunction Treatment Drugs, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Erectile Dysfunction Treatment Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Type (2020-2025)
 Table 25. Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Type (2026-2031)
 Table 27. Global Erectile Dysfunction Treatment Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Application (2020-2025)
 Table 29. Global Erectile Dysfunction Treatment Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Erectile Dysfunction Treatment Drugs Revenue Market Share by Application (2026-2031)
 Table 31. North America Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Erectile Dysfunction Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Erectile Dysfunction Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Erectile Dysfunction Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Erectile Dysfunction Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pfizer Inc. Company Details
 Table 47. Pfizer Inc. Business Overview
 Table 48. Pfizer Inc. Erectile Dysfunction Treatment Drugs Product
 Table 49. Pfizer Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 50. Pfizer Inc. Recent Development
 Table 51. Dong-A Pharmaceutical Co. Ltd Company Details
 Table 52. Dong-A Pharmaceutical Co. Ltd Business Overview
 Table 53. Dong-A Pharmaceutical Co. Ltd Erectile Dysfunction Treatment Drugs Product
 Table 54. Dong-A Pharmaceutical Co. Ltd Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 55. Dong-A Pharmaceutical Co. Ltd Recent Development
 Table 56. Vivus, Inc. Company Details
 Table 57. Vivus, Inc. Business Overview
 Table 58. Vivus, Inc. Erectile Dysfunction Treatment Drugs Product
 Table 59. Vivus, Inc. Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 60. Vivus, Inc. Recent Development
 Table 61. Meda Pharmaceuticals Company Details
 Table 62. Meda Pharmaceuticals Business Overview
 Table 63. Meda Pharmaceuticals Erectile Dysfunction Treatment Drugs Product
 Table 64. Meda Pharmaceuticals Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 65. Meda Pharmaceuticals Recent Development
 Table 66. Bayer AG Company Details
 Table 67. Bayer AG Business Overview
 Table 68. Bayer AG Erectile Dysfunction Treatment Drugs Product
 Table 69. Bayer AG Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 70. Bayer AG Recent Development
 Table 71. Johnson & Johnson Services Company Details
 Table 72. Johnson & Johnson Services Business Overview
 Table 73. Johnson & Johnson Services Erectile Dysfunction Treatment Drugs Product
 Table 74. Johnson & Johnson Services Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 75. Johnson & Johnson Services Recent Development
 Table 76. Apricus Biosciences Company Details
 Table 77. Apricus Biosciences Business Overview
 Table 78. Apricus Biosciences Erectile Dysfunction Treatment Drugs Product
 Table 79. Apricus Biosciences Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 80. Apricus Biosciences Recent Development
 Table 81. Eli Lilly Company Details
 Table 82. Eli Lilly Business Overview
 Table 83. Eli Lilly Erectile Dysfunction Treatment Drugs Product
 Table 84. Eli Lilly Revenue in Erectile Dysfunction Treatment Drugs Business (2020-2025) & (US$ Million)
 Table 85. Eli Lilly Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Erectile Dysfunction Treatment Drugs Picture
 Figure 2. Global Erectile Dysfunction Treatment Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Erectile Dysfunction Treatment Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Phosphodiesterase Type 5 Inhibitors Features
 Figure 5. Prostaglandin E1 Features
 Figure 6. Global Erectile Dysfunction Treatment Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Erectile Dysfunction Treatment Drugs Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Others Case Studies
 Figure 11. Erectile Dysfunction Treatment Drugs Report Years Considered
 Figure 12. Global Erectile Dysfunction Treatment Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Erectile Dysfunction Treatment Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Erectile Dysfunction Treatment Drugs Market Share by Region: 2024 VS 2031
 Figure 15. Global Erectile Dysfunction Treatment Drugs Market Share by Players in 2024
 Figure 16. Global Top Erectile Dysfunction Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Erectile Dysfunction Treatment Drugs as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Erectile Dysfunction Treatment Drugs Revenue in 2024
 Figure 18. North America Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Erectile Dysfunction Treatment Drugs Market Share by Country (2020-2031)
 Figure 20. United States Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Erectile Dysfunction Treatment Drugs Market Share by Country (2020-2031)
 Figure 24. Germany Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Erectile Dysfunction Treatment Drugs Market Share by Region (2020-2031)
 Figure 32. China Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Erectile Dysfunction Treatment Drugs Market Share by Country (2020-2031)
 Figure 40. Mexico Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Erectile Dysfunction Treatment Drugs Market Share by Country (2020-2031)
 Figure 44. Turkey Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Erectile Dysfunction Treatment Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Pfizer Inc. Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2020-2025)
 Figure 48. Dong-A Pharmaceutical Co. Ltd Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2020-2025)
 Figure 49. Vivus, Inc. Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2020-2025)
 Figure 50. Meda Pharmaceuticals Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2020-2025)
 Figure 51. Bayer AG Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2020-2025)
 Figure 52. Johnson & Johnson Services Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2020-2025)
 Figure 53. Apricus Biosciences Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2020-2025)
 Figure 54. Eli Lilly Revenue Growth Rate in Erectile Dysfunction Treatment Drugs Business (2020-2025)
 Figure 55. Bottom-up and Top-down Approaches for This Report
 Figure 56. Data Triangulation
 Figure 57. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS